我們已在上線! 進一步了解
CNSP圖示

CNS Pharmaceuticals

名稱 持股 交易金額 股數
變動
持股
變動
Ikarian Capital
1
Ikarian Capital
Texas
US$64.9萬 +US$37.8萬 +90,000 +196%
ADAR1 Capital Management
2
ADAR1 Capital Management
Texas
US$33.5萬 +US$29.4萬 +70,000 新
SCM
3
Stonepine Capital Management
Oregon
US$19.9萬 -US$8.16萬 -19,427 -32%
Boothbay Fund Management
4
Boothbay Fund Management
New York
US$6.46萬 – – –
Vanguard Fiduciary Trust
5
Vanguard Fiduciary Trust
Pennsylvania
US$4.89萬 +US$4.29萬 +10,226 新
Vanguard Capital Management
6
Vanguard Capital Management
Pennsylvania
US$3.34萬 +US$2.94萬 +6,993 新
UBS Group
7
UBS Group
Switzerland
US$6,983 +US$3,074 +732 +100%
Tower Research Capital (TRC)
8
Tower Research Capital (TRC)
New York
US$3,819 -US$2,146 -511 -39%
Barclays
9
Barclays
United Kingdom
US$91 +US$80 +19 新
BC
10
Barrett & Company
Rhode Island
US$38 – – –
Danske Bank
11
Danske Bank
Denmark
US$5 – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -US$5.57萬 -23,189 已平倉
Sound Income Strategies
13
Sound Income Strategies
Florida
– -US$36 -16 已平倉
MAI Capital Management
14
MAI Capital Management
Ohio
– -US$8 -3 已平倉
Caitong International Asset Management
15
Caitong International Asset Management
Hong Kong
– -US$2 -1 已平倉
Citigroup
16
Citigroup
New York
– -US$2 -1 已平倉